Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: A preclinical comparison

Simone Boehrer; Lionel Adès; Lorenzo Galluzzi; Nicolas Tajeddine; Maximilien Tailler; Claude Gardin; Stéphane de Botton; Pierre Fenaux; Guido Guido Kroemer

doi:10.1016/j.bcp.2008.05.024

Related publications

Article2009

Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome

Simone Boehrer, Lionel Adès, Nicolas Tajeddine, W.-K. Hofmann, Susanne Kriener, Gesine Bug, Oliver G. Ottmann, Martin Ruthardt, Lorenzo Galluzzi, Celine Fouassier, Maximilien Tailler, Ken A. Olaussen, Claude Gardin, Virginie Éclache, Stéphane de Botton, Sylvain Thépot, Pierre Fenaux, Guido Guido Kroemer

Article2012

Erlotinib antagonizes ABC transporters in acute myeloid leukemia

Élodie Lainey, Marie Sébert, Sylvain Thépot, Marie Scoazec, Cyrielle Bouteloup, Carole Leroy, Stéphane de Botton, Lorenzo Galluzzi, Pierre Fenaux, Guido Guido Kroemer

Article2008

Selective Suppression of the DNA Damage Response in Acute Myeloid Leukemia Versus Myelodysplastic Syndrome.

Simone Boehrer, Lionel Adès, Nicolas Tajeddine, Lorenzo Galluzzi, Wolf‐Karsten Hofmann, Pierre Fenaux, Guido Guido Kroemer

Article2009

P068 Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome

Simone Boehrer, Lionel Adès, Claude Gardin, W.-K. Hofmann, Pierre Fenaux, Guido Guido Kroemer

Article2014

A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure

Sylvain Thépot, Simone Boehrer, Valérie Seegers, Thomas Prébet, Odile Beyne‐Rauzy, Eric Wattel, Jacques Delaunay, Emmanuel Raffoux, Mathilde Hunault, Éric Jourdan, Fatiha Chermat, Marie Sébert, Guido Guido Kroemer, Pierre Fenaux, Lionel Adès